pantoprazole has been researched along with Chest Pain in 5 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Chest Pain: Pressure, burning, or numbness in the chest.
| Excerpt | Relevance | Reference |
|---|---|---|
| "All NCCP patients underwent impedance-pH monitoring and on the basis of the results, those with abnormal distal esophageal acid exposure received PPIs twice daily (group A), those with a positive symptom index for chest pain received citalopram 20 mg and PPI once daily (group B), and those with a negative symptom index for chest pain received citalopram 20 mg once daily (group C)." | 3.85 | Proton pump inhibitor and selective serotonin reuptake inhibitor therapy for the management of noncardiac chest pain. ( Christidou, A; Denaxas, K; Galanopoulos, M; Kamberoglou, D; Karamanolis, DG; Karamanolis, G; Katopodi, K; Mantzaris, GJ; Papatheodoridis, G; Tsoukali, E; Varytimiadis, L; Viazis, N, 2017) |
| " A significant reduction in chest pain after pantoprazole therapy (P=." | 3.80 | [What is the utility of proton pump inhibitor testing in non-cardiac chest pain?]. ( Aliaga, V; Domenech, G; Huamán, JW; Saperas, E; Videla, S, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Viazis, N | 1 |
| Katopodi, K | 1 |
| Karamanolis, G | 1 |
| Denaxas, K | 1 |
| Varytimiadis, L | 1 |
| Galanopoulos, M | 1 |
| Tsoukali, E | 1 |
| Kamberoglou, D | 1 |
| Christidou, A | 1 |
| Karamanolis, DG | 1 |
| Papatheodoridis, G | 1 |
| Mantzaris, GJ | 1 |
| Huamán, JW | 1 |
| Aliaga, V | 1 |
| Domenech, G | 1 |
| Videla, S | 1 |
| Saperas, E | 1 |
| Dietrich, CG | 1 |
| Laupichler, S | 1 |
| Stanzel, S | 1 |
| Winograd, R | 1 |
| Al-Taie, O | 1 |
| Gartung, C | 1 |
| Geier, A | 1 |
| Kunsch, S | 1 |
| Spaniol, U | 1 |
| Fensterer, H | 1 |
| Kaechele, V | 1 |
| Adler, G | 1 |
| Ellenrieder, V | 1 |
| Go, H | 1 |
| Yang, HW | 1 |
| Jung, SH | 1 |
| Park, YA | 1 |
| Lee, JY | 1 |
| Kim, SH | 1 |
| Lim, SH | 1 |
1 trial available for pantoprazole and Chest Pain
| Article | Year |
|---|---|
Origin of and therapeutic approach to cardiac syndrome X: results of the proton pump inhibitor therapy for angina-like lingering pain trial (PITFALL trial).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Chest Pain; Coronary Angiography; Double-Blind Method | 2008 |
4 other studies available for pantoprazole and Chest Pain
| Article | Year |
|---|---|
Proton pump inhibitor and selective serotonin reuptake inhibitor therapy for the management of noncardiac chest pain.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Chest Pain; Citalopram; Drug Therapy, Combination; Electric | 2017 |
[What is the utility of proton pump inhibitor testing in non-cardiac chest pain?].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Chest Pain; Cohort Studies; Diagnosis, Differential; Esopha | 2014 |
[Reflux-associated nutcracker oesophagus in a 49-year-old patient with non-cardiac chest pain (NCCP)].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Chest Pain; Esophageal Motility Disorder | 2007 |
Esophageal thermal injury by hot adlay tea.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Burns; Chest Pain; Deglutition Dis | 2007 |